Malaysia vs Sub-Saharan Africa: Antiretroviral therapy coverage for PMTCT
Malaysia
99.0%
in 2024
Sub-Saharan Africa
89.5%
in 2024
Malaysia rank
5th
Sub-Saharan Africa rank
2nd
Antiretroviral therapy coverage for PMTCT over time
- Malaysia
- Sub-Saharan Africa
How they compare
Malaysia currently reports 99.0% against 89.5% in Sub-Saharan Africa, a difference of 9.5%.
That makes Malaysia's figure about 1.1 times Sub-Saharan Africa's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Malaysia ahead.
Malaysia ranks 5th and Sub-Saharan Africa ranks 2nd of 84 countries.
Across the 3 decades both report, Malaysia averaged higher in 2 and Sub-Saharan Africa in 1.
Head to head by decade
| Decade | Malaysia | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.7% | 20.9% | 65.8% | Malaysia |
| 2010s | 77.3% | 78.2% | 0.9% | Sub-Saharan Africa |
| 2020s | 98.0% | 88.6% | 9.4% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Malaysia or Sub-Saharan Africa?
- Malaysia, at 99.0% against 89.5% in Sub-Saharan Africa as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Malaysia and Sub-Saharan Africa?
- 9.5%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Sub-Saharan Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Malaysia and Sub-Saharan Africa rank globally for antiretroviral therapy coverage for pmtct?
- Malaysia ranks 5th and Sub-Saharan Africa ranks 2nd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).